Interaction with host stroma as a promotional factor in tumor malignancy
Anticancer Research
|May 1, 1984
Summary
Yoshida sarcoma cells in rats show significant nuclear variation. Hyperchromatic nuclei in tumor cells are closely associated with stromal elements, suggesting a promotional effect.
Area of Science:
- Oncology
- Cell Biology
- Cancer Research
Background:
- Yoshida sarcoma is a type of cancer that can be studied in rats.
- Tumor cells are known to interact with their surrounding environment, known as the stroma.
- Understanding these interactions is crucial for developing effective cancer therapies.
Purpose of the Study:
- To investigate the heterogeneity of Yoshida sarcoma cells in rats.
- To examine the relationship between tumor cell nuclei morphology and stromal elements.
- To explore the potential role of stromal influences in tumor promotion.
Main Methods:
- Subcutaneous implantation of Yoshida sarcoma cells in rats.
- Microscopic examination of tumor cell nuclei.
- Analysis of the association between tumor cells and stromal elements.
Main Results:
- Yoshida sarcoma cells exhibited heterogeneity in nuclear morphology, ranging from vesicular to irregular and hyperchromatic.
- Cells with hyperchromatic nuclei showed a close association with stromal components.
- This association supports the hypothesis that stromal factors may promote tumor cell growth.
Conclusions:
- Yoshida sarcoma cells are heterogeneous, with distinct nuclear characteristics.
- Stromal elements appear to interact closely with tumor cells, particularly those with hyperchromatic nuclei.
- These findings suggest a potential role for stromal influences in promoting Yoshida sarcoma progression, although the specific factors remain speculative.
More Related Videos
07:44Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports
Published on: November 28, 2019
07:20A Novel Stromal Fibroblast-Modulated 3D Tumor Spheroid Model for Studying Tumor-Stroma Interaction and Drug Discovery
Published on: February 28, 2020
Related Concept Videos
Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
The Tumor Microenvironment
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
Cancer Stem Cells and Tumor Maintenance
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
The Tumor Microenvironment
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
Cancer Stem Cells and Tumor Maintenance
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
